IPSC
Price
$0.91
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Capitalization
77.32M
54 days until earnings call
NKTX
Price
$2.47
Change
-$0.02 (-0.80%)
Updated
Jan 17 closing price
Capitalization
174.3M
61 days until earnings call
Ad is loading...

IPSC vs NKTX

Header iconIPSC vs NKTX Comparison
Open Charts IPSC vs NKTXBanner chart's image
Century Therapeutics
Price$0.91
Change-$0.00 (-0.00%)
Volume$373.34K
Capitalization77.32M
Nkarta
Price$2.47
Change-$0.02 (-0.80%)
Volume$1.77M
Capitalization174.3M
IPSC vs NKTX Comparison Chart
Loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. NKTX commentary
Jan 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and NKTX is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 18, 2025
Stock price -- (IPSC: $0.91 vs. NKTX: $2.47)
Brand notoriety: IPSC and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 56% vs. NKTX: 100%
Market capitalization -- IPSC: $77.32M vs. NKTX: $174.3M
IPSC [@Biotechnology] is valued at $77.32M. NKTX’s [@Biotechnology] market capitalization is $174.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 5 TA indicator(s) are bullish while NKTX’s TA Score has 3 bullish TA indicator(s).

  • IPSC’s TA Score: 5 bullish, 2 bearish.
  • NKTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than NKTX.

Price Growth

IPSC (@Biotechnology) experienced а -8.15% price change this week, while NKTX (@Biotechnology) price change was +5.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

IPSC is expected to report earnings on May 08, 2025.

NKTX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($174M) has a higher market cap than IPSC($77.3M). NKTX YTD gains are higher at: -0.803 vs. IPSC (-9.970). IPSC (-117.21M) and NKTX (-119.34M) have comparable annual earnings (EBITDA) . NKTX has more cash in the bank: 283M vs. IPSC (198M). IPSC has less debt than NKTX: IPSC (54.6M) vs NKTX (85.4M). IPSC has higher revenues than NKTX: IPSC (2.68M) vs NKTX (0).
IPSCNKTXIPSC / NKTX
Capitalization77.3M174M44%
EBITDA-117.21M-119.34M98%
Gain YTD-9.970-0.8031,241%
P/E RatioN/AN/A-
Revenue2.68M0-
Total Cash198M283M70%
Total Debt54.6M85.4M64%
TECHNICAL ANALYSIS
Technical Analysis
IPSCNKTX
RSI
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 11 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
68%
Bearish Trend 11 days ago
90%
Momentum
ODDS (%)
Bullish Trend 11 days ago
86%
Bearish Trend 11 days ago
90%
MACD
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
80%
Bearish Trend 11 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 17 days ago
86%
Declines
ODDS (%)
Bearish Trend 20 days ago
90%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DLDCX39.580.21
+0.53%
BNY Mellon Natural Resources C
HFERX45.200.21
+0.47%
Janus Henderson European Focus N
PSUYX11.66N/A
N/A
Pioneer Global Sustainable Value Y
KMDVX30.38N/A
N/A
Keeley Mid Cap Dividend Value A
JFNNX67.72-0.35
-0.51%
Janus Henderson Global Life Sciences N

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with NKTX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+0.45%
NKTX - IPSC
48%
Loosely correlated
-0.80%
ARVN - IPSC
47%
Loosely correlated
+2.67%
ABCL - IPSC
45%
Loosely correlated
+1.02%
MGTX - IPSC
45%
Loosely correlated
+5.56%
FATE - IPSC
44%
Loosely correlated
+1.60%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-0.80%
FATE - NKTX
49%
Loosely correlated
+1.60%
IPSC - NKTX
49%
Loosely correlated
+0.45%
ALLO - NKTX
48%
Loosely correlated
-1.09%
BEAM - NKTX
45%
Loosely correlated
+0.17%
PRME - NKTX
45%
Loosely correlated
+0.70%
More